作者: Nicholas E. Goeders
DOI:
关键词: Sympathetic nervous system 、 Pharmacology 、 Active ingredient 、 Anxiolytic 、 Addiction 、 Prefrontal cortex 、 Medicine 、 During menopause
摘要: The present invention is based, in part, on our discovery that certain types of therapeutic agents can be used combination to treat a variety neuropsychiatric and related disorders, including addiction (e.g., substance or an activity) as well alleviate some the symptoms experienced during menopause associated with menstrual cycle. Regardless precise formulation, compositions include at least one active ingredient targets hypothalamo- pituitary-adrenal (HPA) axis prefrontal cortex. Either both these combined agent inhibits activity sympathetic nervous system. Thus, pharmacotherapies also beta-adrenergic receptor otherwise acts anti-hypertensive anxiolytic agent.